CRVL CORVEL CORP Insider Trading

Michael G Combs, then-CEO of CRVL, sold 21,000 shares for $1,279,738.60 via scheduled 10b5-1 plan

Michael G Combs, who held the title of CEO & President at the time of filing, executed 3 separate sales totaling 21,000 shares for $1,279,738.60 across June 9–11, 2026, at prices ranging from $60.55 to $61.38. The sales reduced his holdings by 62.1% from 33,822 to 12,822 shares. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning the sales were scheduled rather than discretionary. His prior open-market track record across all tickers shows an average 90-day return of -64.1% following sales, and his 3 prior same-ticker sales at CRVL show 30-day declines of -67.0% and -66.7%, though current price context shows the stock has recovered 5.4% over the prior 30 days and 15.5% over 90 days from the transaction dates. The substantive signal here is the magnitude of the reduction in his direct equity stake—a loss of more than six-tenths of his position—though the scheduled nature of the plan limits what can be inferred about his current sentiment versus ordinary portfolio management mechanics.

Shishin Maxim sold 18,000 shares at $87.82 for $1,580,823.00, reducing CIO stake by 71.9%

Shishin Maxim, Chief Information Officer of CORVEL CORP, executed 2 separate sales totaling 18,000 (18.0K shares) for $1,580,823.00 ($1.6M) on 2025-09-11, with a blended average price of $87.82. This represents a substantial reduction in his holdings from 25,050 shares (25.0K shares) to 7,050 shares (7.0K shares), a net change of -71.9% versus pre-transaction holdings. The sale occurred when the stock is trading at $85.59, which is -33.4% from the 52-week high of $128.46, and has declined -5.5% over 30 days and -18.5% over 90 days. Notably, Maxim's prior trades at CRVL show a strong historical pattern: 4 of 4 measurable prior sells were well-timed at the 90-day mark (30-day returns of -66.6% to -70.5%, and 90-day returns of -60.1% to -70.0%), suggesting his selling decisions have preceded declines in the stock price. Investors should track whether this large divestiture follows the same pattern, though the depressed valuation relative to the 52-week high and recent underperformance warrant attention to company fundamentals and broader sector dynamics.

10% owner CORSTAR HOLDINGS sells 40,000 shares of CRVL at $88.85; stock -29.7% from 52-week high, insider's 4 prior CRVL sales all well-timed at 90-day horizon.

CORSTAR HOLDINGS, a 10% stakeholder, sold 40,000 shares at $88.85 on 2025-09-02, reducing holdings by 0.2%. The sale occurred as CRVL is trading -29.7% from its 52-week high of $128.46, though the stock has gained +4.8% over the past 30 days. Critically, this insider's prior trading history at this same ticker shows a pattern of well-timed execution: 4 of 4 prior sells at CRVL produced negative 90-day returns ranging from -60.6% to -61.2%, indicating consistent ability to sell ahead of declines. The insider's cross-ticker track record reinforces this pattern, with a 100.00% well-timed rate on 16 prior sells (average 90-day return -61.2%). Given CRVL's current valuation (P/E 46.09) and the insider's demonstrated timing discipline at this specific ticker, this sale warrants investor attention as a potential leading indicator of near-term weakness.

CIO Shishin Maxim sold 12,000 CRVL shares at $89.16; 90-day returns on 5 prior CRVL sales all negative, averaging -63.2%.

Shishin Maxim (CIO) sold 12,000 shares (12.0K shares) on 2025-08-20 at $89.16 for $1,069,976.40, reducing holdings by 63.0% from 19,050 to 7,050 shares. This sale occurs in a notable pattern: all 5 of his prior trades at CRVL were sales, and each was followed by stock declines of 60% to 71% within 90 days. His cross-ticker track record shows 100.00% well-timed rate on 6 prior sells with avg 90d return of -63.6%. The stock is currently trading at $90.06, down 29.9% from its 52-week high of $128.46. The consistency of negative 90-day returns following his prior CRVL sales (all 5 previous trades showing 90d declines) suggests a pattern in his exit timing, though the company itself remains profitable with $234.7M quarterly revenue, +12.6% annual growth, and a P/E of 45.95.

Director Jeffrey sold 16,523 shares for $1.9M at blended $116.99, retains 551.8K shares post-sale.

MICHAEL JEFFREY J, a Director at CORVEL CORP, executed 2 separate sales totaling 16,523 shares for $1,933,010.75 on 2025-04-09 at a blended average price of $116.99. The sales represent a 2.9% reduction from his pre-transaction holdings of 568,310 shares, leaving him with 551,787 shares post-transaction. At current price of $114.90, the transactions were executed above current market levels. His prior sales at CRVL on 2025-02-20 (3 separate sales) produced negative 30-day returns of -7.2%, -9.0%, and -7.9%, though 90-day outcomes remain unmeasurable. The company carries a high P/E of 66.80, operating with recent quarterly revenue of $227,973,000.00 and net income of $23,771,000.00, with annual revenue growth of +10.7%.

Director Michael Jeffrey sold 10,477 shares for $1.2M at $116.45 avg; current price $106.17, down 17.4% from 52-week high

Michael Jeffrey, a Director at Corvel Corp, executed 3 separate sales totaling 10,477 shares for $1,220,099.01 on February 20, 2025, at a blended average price of $116.45. His post-transaction holdings remain substantial at 568,310 shares, representing only a 1.8% reduction from his pre-transaction position. The timing of these sales is notable given the stock's recent weakness: the current price of $106.17 sits 17.4% below the 52-week high and has declined 8.6% over the past 30 days. While the transaction occurred at prices well above current levels, the modest percentage reduction in his overall stake suggests a limited directional conviction signal, though the execution across three separate price points within a single trading day warrants attention to the filing circumstances.

Director Alan Hoops sells 10,200 shares at $116.39 avg (2 trades); prior sells at CRVL 100% well-timed on 90-day view

Alan Hoops, a director at Corvel Corp, executed two separate sales on 2025-02-18 totaling 10,200 shares for $1,187,220.00 at an average price of $116.39, reducing his holdings by 7.9%. His prior trade history at CRVL is notably consistent: all 4 of his previous sales at this ticker were well-timed at the 90-day mark, with post-sale declines ranging from -62.8% to -66.9%, establishing a clear pattern of selling ahead of downturns. The current stock price of $114.27 is already -11.0% from the 52-week high of $128.46, and his cross-ticker track record shows a 100.00% 90-day well-timed rate across all open-market activity, though this particular sale occurred at prices above the current market level. The stock trades at a P/E of 66.44 with modest recent momentum (30-day +3.5%, 90-day -7.5%), presenting a mixed technical backdrop for near-term price action.

Director HAMERSLAG STEVEN J sold 10,000 shares of CRVL at $123.48 on 2025-02-06; strong pattern of well-timed prior exits at this ticker.

HAMERSLAG STEVEN J, a director, sold 10,000 shares (10.0K shares) at $123.48 on 2025-02-06, reducing his holdings from 324,000 to 314,000 shares. His prior trades at CRVL—5 previous transactions, all sales—have demonstrated consistent success: all 5 prior sells were well-timed at the 90-day mark with negative 90-day returns ranging from -63.8% to -66.7%, meaning the stock declined after each sale. The current transaction occurred at $123.48, near the 52-week high of $128.46 and well above the current price of $117.39, positioning this sale above recent market levels. This latest transaction aligns with an established pattern: a director with a 100% success rate at timing exits from this specific stock, acting again as valuations approach cyclical highs.

CRVL Chairman Gordon sells 8,000 shares in 2 transactions for $2,925,306.60 (Nov 29–Dec 2)

Chairman Clemons V Gordon executed 2 separate sales totaling 8,000 shares for $2,925,306.60, reducing his stake by 3.2% to 241,584 shares post-transaction. The stock has risen 17.9% over the past 30 days and 14.4% over 90 days, trading at $118.70 (-3.9% from its 52-week high of $123.54). Gordon's cross-ticker track record shows a 100.00% well-timed sell rate historically, though his 5 prior CRVL sales remain too recent to measure outcomes. With CRVL trading at a P/E of 24.94 and posting 10.7% annual revenue growth on a $2.0B market cap, this sale represents a material but not controlling reduction in the Chairman's position during a period of positive price momentum.

Chairman V. Gordon Clemons sells 11,200 shares of CRVL for $4.1M ($368.80 avg) over 5 days, retaining 249,584 shares post-transaction

Clemons executed 3 separate sales totaling 11,200 shares for $4,130,612.12 between 2024-11-22 and 2024-11-26, reducing his stake by 4.3% to 249.6K shares. The blended average price of $368.80 significantly exceeds the current price of $123.54, indicating these sales occurred near a local peak; however, stock price has risen 21.9% in the 30 days and 17.8% in the 90 days since filing, contradicting any signal that the sales prefigured a decline. His same-ticker prior sales at CRVL (2023-11-14 and 2023-09-15) showed well-timed outcomes at the 90-day mark, but those measurable results occurred in a different market window; the current 30-day and 90-day periods post-transaction show price appreciation rather than decline. The company's 10.7% annual revenue growth and P/E of 25.95 suggest a moderately valued, growing business; the sale does not appear driven by deteriorating fundamentals.